OpenEye, Cadence Molecular Sciences · 1 month ago
Principal UI/UX Designer (R51595/gs)
Cadence Molecular Sciences has developed a cutting-edge cloud-native platform for molecular design, and they are seeking an outstanding UX/UI designer to lead the design of the Orion platform. The role involves conducting user research, creating design solutions, and collaborating with various teams to enhance the user experience of therapeutic design.
Responsibilities
Conduct high-quality user research to develop user personas and design strategy that can be articulated in a complete user experience
Create and iteratively refine design solutions through mocks, wireframes and high-fidelity prototypes
Measure product success and value delivery through analytics
Participate in formulating strategic product vision as it relates to user experience design
Coach stakeholders in key aspects of design
Contribute to building design resources with developers (e.g., UI component libraries)
Qualification
Required
BS with a minimum of 7 years of experience OR MS with a minimum of 5 years of experience OR PhD with a minimum of 1 year of experience
3+ years' experience in UX/UI design at an agile, SaaS or similar organization
Excellent user research skills and an ability to synthesize and translate technical user research and experience into elegant visual design
Well-acquainted with design tools such as Balsamiq, Sketch, Figma, InVision, etc
A history of working with diverse stakeholders including front-end engineers, customers and product representatives
Preferred
Extensive experience working closely with an engineering team
Ability to work with PhD scientists and users
Understanding of molecules, chemistry, pharmaceuticals or a related field
A background or experience in software engineering for a STEM discipline
Experience working on cloud-based SAAS services
Company
OpenEye, Cadence Molecular Sciences
OpenEye, Cadence Molecular Sciences is an industry leader in computational molecular design based on decades of delivering rapid, robust, and scalable software, toolkits, and technology and design services across the drug discovery process.
Funding
Current Stage
Growth StageTotal Funding
unknown2022-07-25Acquired
Leadership Team
Recent News
2025-02-16
Company data provided by crunchbase